Abstract: A cooling box to control temperature so that an internal temperature of the cooling box becomes equal to a set temperature, includes: a control device including an temperature sensor to detect an ambient temperature of the box, and adjust a supply amount of warm air into the box after stopping supply of cold air thereinto based on the ambient temperature; and a door sensor to detect whether an opening connected with the interior of the cooling box is in either an open or closed state, when the door sensor detects a change of the opening from an open to closed state. The control device executes control so that the warm-air-supply-amount reaches a first value until a predetermined period has elapsed, and executes control so that the warm-air-supply-amount reaches a second value smaller than the first value after the predetermined period has elapsed.

Abstract: A low-temperature storage includes: a thermally-insulating casing including an accommodating portion accommodating an item to be refrigerated; a door to be closed in a manner capable of opening/closing the portion; a cooling mechanism cooling an interior thereof; a temperature-detecting unit measuring a temperature in the portion; an opening/closing-detecting unit detecting a door open/close state; and a control unit including a temperature-adjusting unit controlling the cooling mechanism so that the temperature reaches a target temperature, first- and second-temperature-storing units storing first and second temperatures, respectively, a target-temperature-setting unit setting the target temperature at the first temperature when the opening/closing-detecting unit detects that the door has changed from an open to closed state, and thereafter, setting the target temperature at the second temperature, and a control-information-setting unit setting the first or second temperatures, and when a difference therebet

Abstract: A disclosed data encoding apparatus includes: an arbitrary number of storage units; a data transfer control unit dividing input data into data blocks in accordance with the arbitrary number of storage units and transferring the data blocks to each storage unit; and encoding units having the same number as the storage units, the encoding units encoding the data blocks using a different cryptographic key for each storage unit while the data blocks are transferred by the data transfer control unit, wherein each storage unit stores the data blocks encoded by the encoding units.

Abstract: An image forming apparatus includes an image forming unit for forming an image; a status conversion unit for converting the multi-value pixel data into status values; plural reference look-up tables each indicating an association between an arrangement of the status values of a target pixel and adjacent pixels in a pixel window and an output data value of the multi-value pixel data to be output; a determining unit for determining a target reference look-up table based on the arrangement; and a generating unit configured to change an input data value of the multi-value pixel data, into the output data value of the determined target reference look-up table, and for outputting the multi-value pixel data to the image forming unit.

Abstract: A cooling box to perform temperature control so that an internal temperature of the cooling box storing an item to be refrigerated becomes equal to a set temperature includes: a control device including an ambient-temperature sensor to detect an ambient temperature of the box, and adjust a supply amount of warm air into the box after stopping supply of cold air thereinto based on the ambient temperature; and a thermally-insulating-door sensor to detect whether an opening connected with the interior of the cooling box is in either an open or closed state, when the sensor detects a change of the opening from an open to closed state, the control device executing control so that the warm-air-supply-amount reaches a first value until a predetermined period has elapsed, and executing control so that the warm-air-supply-amount reaches a second value smaller than the first value after the predetermined period has elapsed.

Abstract: A low-temperature storage includes: a thermally-insulating casing including an accommodating portion accommodating an item to be refrigerated; a door to be closed in a manner capable of opening/closing the portion; a cooling mechanism cooling an interior thereof; a temperature-detecting unit measuring a temperature in the portion; an opening/closing-detecting unit detecting a door open/close state; and a control unit including a temperature-adjusting unit controlling the cooling mechanism so that the temperature reaches a target temperature, first- and second-temperature-storing units storing first and second temperatures, respectively, a target-temperature-setting unit setting the target temperature at the first temperature when the opening/closing-detecting unit detects that the door has changed from an open to closed state, and thereafter, setting the target temperature at the second temperature, and a control-information-setting unit setting the first or second temperatures, and when a difference therebet

Abstract: An apparatus and a method of controlling a light level of a light beam irradiated by a light source are provided. The light source is caused to irradiate the light beam having a light level determined based on a light level correction value for a specific main scanning position. The light level correction value is calculated based on light level change information indicating the change in the light level correction value for the specific main scanning position changes with respect to an initial light level correction value or a preceding light level correction value.

Abstract: The present invention relates to an ester represented by the formula [1]: or its pharmaceutically acceptable salt, or use of the same. The compound represented by the formula [1] or its pharmaceutically acceptable salt is useful as an agent for the treatment or prophylaxis of hyperlipidemia or the like, since it disappears very rapidly in the living body and has an excellent MTP inhibitory activity.

Abstract: Compounds, compositions and methods are provided that are useful in the treatment or prevention of a condition or disorder mediated by PPAR?. In particular, the compounds of the invention modulate the function of PPAR?. The subject methods are particularly useful in the treatment and/or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis.

Abstract: An apparatus and a method of controlling a light level of a light beam irradiated by a light source are provided. The light source is caused to irradiate the light beam having a light level determined based on a light level correction value for a specific main scanning position. The light level correction value is calculated based on light level change information indicating the change in the light level correction value for the specific main scanning position changes with respect to an initial light level correction value or a preceding light level correction value.

Abstract: A novel therapeutic agent for hyperlipidemia, which is an ester compound represented by the formula (1?) (wherein R1 and R2 are each hydrogen atom or optionally substituted aryl, etc.; X is —COO— or —CON(R10)—; R3 and R4 are each hydrogen atom, C1-C6 alkyl or C1-C6 alkoxy, etc.; R5, R6 and R7 are each hydrogen atom, C1-C6 alkyl or C1-C6 alkoxy, etc.; R9 and R9 are each independently hydrogen atom, C1-C6 alkyl, —CON(R18) (R19) or —COO(R20), etc.; ring A, ring B and ring C are each independently aryl or heterocycle residue, etc.; Alk1 and Alk2 are each independently alkanediyl, etc.; l and m are each an integer of 0 or 1 to 3) or a prodrug thereof, or a pharmaceutically acceptable salt of either. The therapeutic agent selectively inhibits MTP in the small intestine, thus causes no such side effect as a fatty liver.

Abstract: A novel therapeutic agent for hyperlipidemia, which is an ester compound represented by the formula (1?) (wherein R1 and R2 are each hydrogen atom or optionally substituted aryl, etc.; X is —COO— or —CON(R10)—; R3 and R4 are each hydrogen atom, C1-C6alkyl or C1-C6alkoxy, etc.; R5, R6 and R7 are each hydrogen atom, C1-C6 alkyl or C1-C6 alkoxy, etc.; R8 and R9 are each independently hydrogen atom, C1-C6alkyl, —CON(R18)(R19) or —COO(R20), etc.; ring A, ring B and ring C are each independently aryl or heterocycle residue, etc.; Alk1 and Alk2 are each independently alkanediyl, etc.; l and m are each an integer of 0 or 1 to 3) or a prodrug thereof, or a pharmaceutically acceptable salt of either. The therapeutic agent selectively inhibits MTP in the small intestine, thus causes no such side effect as a fatty liver.

Abstract: Compounds, compositions and methods are provided that are useful in the treatment or prevention of a condition or disorder mediated by PPAR?. In particular, the compounds of the invention modulate the function of PPAR?. The subject methods are particularly useful in the treatment and/or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis.

Abstract: Compounds, compositions and methods are provided that are useful in the treatment or prevention of a condition or disorder mediated by PPAR?. In particular, the compounds of the invention modulate the function of PPAR?. The subject methods are particularly useful in the treatment and/or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis.

Abstract: An image forming apparatus includes an image forming unit for forming an image; a status conversion unit for converting the multi-value pixel data into status values; plural reference look-up tables each indicating an association between an arrangement of the status values of a target pixel and adjacent pixels in a pixel window and an output data value of the multi-value pixel data to be output; a determining unit for determining a target reference look-up table based on the arrangement; and a generating unit configured to change an input data value of the multi-value pixel data, into the output data value of the determined target reference look-up table, and for outputting the multi-value pixel data to the image forming unit.

Abstract: A novel therapeutic agent for hyperlipidemia, which is an ester compound represented by the formula (1?) (wherein R1 and R2 are each hydrogen atom or optionally substituted aryl, etc.; X is —COO— or —CON(R10)—; R3 and R4 are each hydrogen atom, C1-C6alkyl or C1-C6alkoxy, etc.; R5, R6 and R7 are each hydrogen atom, C1-C6 alkyl or C1-C6 alkoxy, etc.; R8 and R9 are each independently hydrogen atom, C1-C6alkyl, —CON(R18)(R19) or —COO(R20), etc.; ring A, ring B and ring C are each independently aryl or heterocycle residue, etc.; Alk1 and Alk2 are each independently alkanediyl, etc.; l and m are each an integer of 0 or 1 to 3) or a prodrug thereof, or a pharmaceutically acceptable salt of either. The therapeutic agent selectively inhibits MTP in the small intestine, thus causes no such side effect as a fatty liver.

Abstract: A therapeutic agent for hyperlipidemia which has no side effects on the liver unlike conventional MTP inhibitors and has excellent MTP inhibitory activity. Also, provided is an ester compound represented by the general formula (1): or a pharmaceutically acceptable salt thereof.

Abstract: A disclosed data encoding apparatus includes: an arbitrary number of storage units; a data transfer control unit dividing input data into data blocks in accordance with the arbitrary number of storage units and transferring the data blocks to each storage unit; and encoding units having the same number as the storage units, the encoding units encoding the data blocks using a different cryptographic key for each storage unit while the data blocks are transferred by the data transfer control unit, wherein each storage unit stores the data blocks encoded by the encoding units.

Abstract: A therapeutic agent for hyperlipidemia which has no side effects on the liver unlike conventional MTP inhibitors and has excellent MTP inhibitory activity. Also, provided is an ester compound represented by the general formula (1): or a pharmaceutically acceptable salt thereof.

Abstract: The present invention relates to an ester represented by the formula [1]: or its pharmaceutically acceptable salt, or use of the same. The compound represented by the formula [1] or its pharmaceutically acceptable salt is useful as an agent for the treatment or prophylaxis of hyperlipidemia or the like, since it disappears very rapidly in the living body and has an excellent MTP inhibitory activity.